- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Corporate and Securities Litigation
- E-Discovery
- Global Construction and Infrastructure Disputes
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Events 122 results
Speaking Engagement
June 1, 2026
Brian Bohnenkamp to Speak at Seton Hall Law’s U.S. Healthcare Compliance Certificate Program
Webinar
May 14, 2026
A Review of the FY 2027 IPPS and LTCH PPS Proposed Rule: Highlights and What to Expect
Webinar
May 12, 2026
Food & Beverage: Ultra-Processed Foods
Conference
April 8, 2026
Annual California Life Sciences Summit
Speaking Engagement
April 2, 2026
Christina Markus and Geneviève Michaux to Speak at two European Cell and Gene Therapy Research Consortia
Speaking Engagement
March 20, 2026
Lauren Gennett and Rob DeConti to Speak at the North Carolina Bar Association
Webinar
February 25, 2026
Data Dividends vs. Red Lines: Navigating EU Data Laws and Cyber Threats in Pharma’s Data‑Driven Era
Webinar
January 29, 2026
The Revision of the EU General Pharmaceutical Legislation
Webinar
January 28, 2026
Drug & Device Advertising Year in Review: Lessons from 2025 FDA Enforcement & Key Developments
Webinar
January 8, 2026
Medicare and Medicaid Demos Seek To Impose Most Favored Nation Pricing: An Overview of GLOBE, GUARD, and GENEROUS
Webinar
December 18, 2025
Drug Compounding Litigation Update: Compounder Cases Against FDA and Pharma Company Cases Against Compounders
Speaking Engagement
December 8, 2025
Ulf Grundmann to Speak at Frankfurt School of Finance and Management’s International Healthcare Management MBA program